Burden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry
T. Le (Gaithersburg, United States), C. Erhard (Cambridge, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Maslova (Cambridge, United Kingdom), B. Cook (Gaithersburg, United States), A. Quinton (Cambridge, United Kingdom), R. Katial (Gaithersburg, United States), G. Christoff (Sofia, Bulgaria), L. Perez-De-Llano (Lugo, Spain), V. Carter (Cambridge, United Kingdom), T. Tran (Gaithersburg, United States), T. Tran (Gaithersburg, United States)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2400
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Le (Gaithersburg, United States), C. Erhard (Cambridge, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Maslova (Cambridge, United Kingdom), B. Cook (Gaithersburg, United States), A. Quinton (Cambridge, United Kingdom), R. Katial (Gaithersburg, United States), G. Christoff (Sofia, Bulgaria), L. Perez-De-Llano (Lugo, Spain), V. Carter (Cambridge, United Kingdom), T. Tran (Gaithersburg, United States), T. Tran (Gaithersburg, United States). Burden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry. 2400
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|